AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$630M |
| 2 |
Visa
V
|
+$363M |
| 3 |
MSCI
MSCI
|
+$322M |
| 4 |
Walt Disney
DIS
|
+$297M |
| 5 |
Monster Beverage
MNST
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$584M |
| 2 |
Nike
NKE
|
+$573M |
| 3 |
Meta Platforms (Facebook)
META
|
+$489M |
| 4 |
Adobe
ADBE
|
+$418M |
| 5 |
Advanced Micro Devices
AMD
|
+$416M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.76% |
| 2 | Healthcare | 17.68% |
| 3 | Financials | 13.09% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Xerox
XRX
$387M
| $3.39M | ﹤0.01% |
259,329
-10,075
| -4% | -$163K |
|
1577
Ponce Financial Group
PDLB
$488M
| $3.39M | ﹤0.01% |
370,206
+4,248
| +1% | +$39.7K |
|
1578
Bread Financial
BFH
$4.37B
| $3.38M | ﹤0.01% |
107,535
-7,175
| -6% | -$281K |
|
1579
Kura Oncology
KURA
$800M
| $3.38M | ﹤0.01% |
247,345
+95,712
| +63% | +$1.48M |
|
1580
NovoCure
NVCR
$1.73B
| $3.36M | ﹤0.01% |
44,168
-341
| -0.8% | -$26.6K |
|
1581
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.84B
| $3.35M | ﹤0.01% |
112,088
-1,089
| -1% | -$40.6K |
|
1582
Community Trust Bancorp
CTBI
$1.42B
| $3.35M | ﹤0.01% |
82,613
+1,000
| +1% | +$42.4K |
|
1583
Beam Therapeutics
BEAM
$2.63B
| $3.34M | ﹤0.01% |
70,100
+300
| +0.4% | +$17.1K |
|
1584
Albany International
AIN
$2.11B
| $3.33M | ﹤0.01% |
42,286
-17
| -0% | -$1.46K |
|
1585
Golar LNG
GLNG
$5B
| $3.33M | ﹤0.01% |
133,600
| – | – |
|
1586
Pacira BioSciences
PCRX
$1.04B
| $3.32M | ﹤0.01% |
62,387
-488
| -0.8% | -$27.1K |
|
1587
MaxLinear
MXL
$6.06B
| $3.32M | ﹤0.01% |
101,674
-378
| -0.4% | -$14K |
|
1588
Plexus
PLXS
$6.72B
| $3.32M | ﹤0.01% |
37,869
+66
| +0.2% | +$5.89K |
|
|
HBI
1589
DELISTED
Hanesbrands
HBI
| $3.31M | ﹤0.01% |
475,372
-245,495
| -34% | -$2.41M |
|
1590
NexGen Energy
NXE
$6.06B
| $3.31M | ﹤0.01% |
900,924
-1,419,248
| -61% | -$5.71M |
|
|
JBGS
1591
JBG SMITH
JBGS
$818M
| $3.29M | ﹤0.01% |
177,118
-23,200
| -12% | -$532K |
|
|
FOLD
1592
DELISTED
Amicus Therapeutics
FOLD
| $3.29M | ﹤0.01% |
314,729
-421,536
| -57% | -$4.7M |
|
1593
Elanco Animal Health
ELAN
$13.2B
| $3.28M | ﹤0.01% |
264,634
-176,305
| -40% | -$3.08M |
|
1594
Mercury Systems
MRCY
$5.83B
| $3.28M | ﹤0.01% |
80,775
-985
| -1% | -$51.6K |
|
1595
Federal Signal
FSS
$7.63B
| $3.27M | ﹤0.01% |
87,740
-12,777
| -13% | -$502K |
|
1596
NETSCOUT
NTCT
$2.96B
| $3.27M | ﹤0.01% |
104,272
-959
| -0.9% | -$31.4K |
|
1597
Steven Madden
SHOO
$3.37B
| $3.26M | ﹤0.01% |
122,388
-22
| -0% | -$693 |
|
1598
Evolent Health
EVH
$348M
| $3.26M | ﹤0.01% |
90,800
| – | – |
|
1599
Peabody Energy
BTU
$2.6B
| $3.26M | ﹤0.01% |
131,400
| – | – |
|
1600
Dorman Products
DORM
$3.98B
| $3.26M | ﹤0.01% |
39,700
+63
| +0.2% | +$6.2K |
|
Similar funds
AllianceBernstein's Q3 2022 Portfolio in Review
As of Q3 2022, AllianceBernstein held 3,359 positions worth $207B, down 5.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
AllianceBernstein's Q3 2022 filing shows 102 new, 1,361 increased, 1,417 reduced and 89 closed positions. Its largest new stake was Genmab: 5,779,489 shares worth $186M. The largest sale was Qualcomm, an estimated $584M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q3 2022 buy was Genmab: 5,779,489 shares worth $186M.
- AllianceBernstein added most to iShares Russell 1000 Growth ETF in Q3 2022, an estimated $630M increase.
- AllianceBernstein's biggest Q3 2022 reduction was Qualcomm, cutting an estimated $584M.
- AllianceBernstein fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $244M.
- AllianceBernstein's ten largest holdings make up 23% of its $207B portfolio in Q3 2022.
- AllianceBernstein opened 102 new positions and closed 89 in Q3 2022.
- AllianceBernstein's portfolio value fell 5.7% quarter-over-quarter to $207B.
Based on AllianceBernstein's 13F filing for Q3 2022, filed 15 Nov 2022.